Literature DB >> 26940127

The 26S proteasome: A cell cycle regulator regulated by cell cycle.

Xing Guo1, Jack E Dixon2,3,4.   

Abstract

Keywords:  DYRK2; cell cycle; phosphorylation; proteasome

Mesh：

Substances：

Year:  2016        PMID： 26940127      PMCID： PMC4889267          DOI： 10.1080/15384101.2016.1151728

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  A quantitative atlas of mitotic phosphorylation.

Authors:  Noah Dephoure; Chunshui Zhou; Judit Villén; Sean A Beausoleil; Corey E Bakalarski; Stephen J Elledge; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

2.  UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity.

Authors:  Xing Guo; James L Engel; Junyu Xiao; Vincent S Tagliabracci; Xiaorong Wang; Lan Huang; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

3.  Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.

Authors:  Richard Marcotte; Azin Sayad; Kevin R Brown; Felix Sanchez-Garcia; Jüri Reimand; Maliha Haider; Carl Virtanen; James E Bradner; Gary D Bader; Gordon B Mills; Dana Pe'er; Jason Moffat; Benjamin G Neel
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

Review 4.  Targeting the ubiquitin system in cancer therapy.

Authors:  Daniela Hoeller; Ivan Dikic
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

Review 5.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

6.  A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.

Authors:  Fabio Petrocca; Gabriel Altschuler; Shen Mynn Tan; Marc L Mendillo; Haoheng Yan; D Joseph Jerry; Andrew L Kung; Winston Hide; Tan A Ince; Judy Lieberman
Journal:  Cancer Cell       Date:  2013-08-12       Impact factor: 31.743
  6 in total
  5 in total

1.  Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.

Authors:  Kai Yuan; Zhaoxing Li; Wenbin Kuang; Xiao Wang; Minghui Ji; Weijiao Chen; Jiayu Ding; Jiaxing Li; Wenjian Min; Chengliang Sun; Xiuquan Ye; Meiling Lu; Liping Wang; Haixia Ge; Yuzhang Jiang; Haiping Hao; Yibei Xiao; Peng Yang
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

Review 2.  Reversible phosphorylation of the 26S proteasome.

Authors:  Xing Guo; Xiuliang Huang; Mark J Chen
Journal:  Protein Cell       Date:  2017-03-03       Impact factor: 14.870

3.  Comparative proteomic analysis of cat eye syndrome critical region protein 1- function in tumor-associated macrophages and immune response regulation of glial tumors.

Authors:  Changbin Zhu; Dana A M Mustafa; Merle M Krebber; Ihsan Chrifi; Pieter J M Leenen; Dirk J Duncker; Lennard Dekker; Theo M Luider; Johan M Kros; Caroline Cheng
Journal:  Oncotarget       Date:  2018-09-11

4.  Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.

Authors:  Mingwei Zhang; Xuezhen Wang; Xiaoping Chen; Qiuyu Zhang; Jinsheng Hong
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

5.  Conserved Mitotic Phosphorylation of a Proteasome Subunit Regulates Cell Proliferation.

Authors:  Jinyuan Duan; Wenzhu Li; Xin Shu; Bing Yang; Xiangwei He; Xing Guo
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.